Translational aspects of sphingolipid metabolism

Youssef Zeidan, Yusuf A. Hannun

Research output: Contribution to journalArticle

92 Citations (Scopus)

Abstract

Sphingolipids, a major class of lipids in cell membranes, play diverse roles in biological processes. As bioactive and structural molecules, they have signaling activities and biophysical properties that are essential for regulating various cellular, tissue and systemic functions. Moreover, sphingolipids are receiving increasing attention as contributors to the pathogenesis of several human disorders, including, cancer, inflammation and neurological, immune and metabolic disorders. Small-molecule inhibitors and monoclonal antibodies that target sphingolipid metabolism recently enabled giant strides toward treatment of malignant and autoimmune disorders. Here, we review the emerging roles of sphingolipids in disease pathogenesis and the attendant possibilities for sphingolipid-based therapeutics.

Original languageEnglish (US)
Pages (from-to)327-336
Number of pages10
JournalTrends in Molecular Medicine
Volume13
Issue number8
DOIs
StatePublished - Aug 2007
Externally publishedYes

Fingerprint

Sphingolipids
Biological Phenomena
Immune System Diseases
Membrane Lipids
Monoclonal Antibodies
Inflammation
Neoplasms

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Translational aspects of sphingolipid metabolism. / Zeidan, Youssef; Hannun, Yusuf A.

In: Trends in Molecular Medicine, Vol. 13, No. 8, 08.2007, p. 327-336.

Research output: Contribution to journalArticle

Zeidan, Youssef ; Hannun, Yusuf A. / Translational aspects of sphingolipid metabolism. In: Trends in Molecular Medicine. 2007 ; Vol. 13, No. 8. pp. 327-336.
@article{cda9eeb40ff241cbbd9d9ec7454e3020,
title = "Translational aspects of sphingolipid metabolism",
abstract = "Sphingolipids, a major class of lipids in cell membranes, play diverse roles in biological processes. As bioactive and structural molecules, they have signaling activities and biophysical properties that are essential for regulating various cellular, tissue and systemic functions. Moreover, sphingolipids are receiving increasing attention as contributors to the pathogenesis of several human disorders, including, cancer, inflammation and neurological, immune and metabolic disorders. Small-molecule inhibitors and monoclonal antibodies that target sphingolipid metabolism recently enabled giant strides toward treatment of malignant and autoimmune disorders. Here, we review the emerging roles of sphingolipids in disease pathogenesis and the attendant possibilities for sphingolipid-based therapeutics.",
author = "Youssef Zeidan and Hannun, {Yusuf A.}",
year = "2007",
month = "8",
doi = "10.1016/j.molmed.2007.06.002",
language = "English (US)",
volume = "13",
pages = "327--336",
journal = "Trends in Molecular Medicine",
issn = "1471-4914",
publisher = "Elsevier Limited",
number = "8",

}

TY - JOUR

T1 - Translational aspects of sphingolipid metabolism

AU - Zeidan, Youssef

AU - Hannun, Yusuf A.

PY - 2007/8

Y1 - 2007/8

N2 - Sphingolipids, a major class of lipids in cell membranes, play diverse roles in biological processes. As bioactive and structural molecules, they have signaling activities and biophysical properties that are essential for regulating various cellular, tissue and systemic functions. Moreover, sphingolipids are receiving increasing attention as contributors to the pathogenesis of several human disorders, including, cancer, inflammation and neurological, immune and metabolic disorders. Small-molecule inhibitors and monoclonal antibodies that target sphingolipid metabolism recently enabled giant strides toward treatment of malignant and autoimmune disorders. Here, we review the emerging roles of sphingolipids in disease pathogenesis and the attendant possibilities for sphingolipid-based therapeutics.

AB - Sphingolipids, a major class of lipids in cell membranes, play diverse roles in biological processes. As bioactive and structural molecules, they have signaling activities and biophysical properties that are essential for regulating various cellular, tissue and systemic functions. Moreover, sphingolipids are receiving increasing attention as contributors to the pathogenesis of several human disorders, including, cancer, inflammation and neurological, immune and metabolic disorders. Small-molecule inhibitors and monoclonal antibodies that target sphingolipid metabolism recently enabled giant strides toward treatment of malignant and autoimmune disorders. Here, we review the emerging roles of sphingolipids in disease pathogenesis and the attendant possibilities for sphingolipid-based therapeutics.

UR - http://www.scopus.com/inward/record.url?scp=34547149529&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34547149529&partnerID=8YFLogxK

U2 - 10.1016/j.molmed.2007.06.002

DO - 10.1016/j.molmed.2007.06.002

M3 - Article

VL - 13

SP - 327

EP - 336

JO - Trends in Molecular Medicine

JF - Trends in Molecular Medicine

SN - 1471-4914

IS - 8

ER -